Over the past several decades, advancements in the treatment of Ewing sarcoma and osteosarcoma have remained limited; both involve intensive and toxic chemotherapy regimens, with patients facing gruelling immediate, long term and late effects of treatment, as well as the risk of relapse and recurrence. Methods of determining prognosis and predicting or monitoring response to treatment are also lacking.
Both charities are committed to improving outcomes for patients and believe the best way to do this is to fund high impact, innovative and collaborative research with the aim of improving outcomes for patients.
Idea (pilot) grant applications
Projects may be discovery focused, where novel research ideas are tested, or proof of concept studies aiming to generate preliminary data for subsequent applications. This funding call can also provide funds for small translational projects that show potential and may pave the way for future major research. Regardless of this focus, applicants must demonstrate that they have considered how the project may result in patient benefit or clinical application, irrespective of timescales.
Funding is available to researchers and / or clinicians working in an academic or clinical institution in the UK or internationally. Applications from younger academics, who do not have a tenured position are encouraged. Funding is usually capped at £35,000, however, this may be increased to £50,000 in exceptional cases. Applicants should contact us to discuss this prior to submitting an application for that value.
Key dates
Call opens 27th April 2026
Closing date for applications: 31st July 2026
Outcomes will be announced by December 2026
Please contact research@bcrt.org.uk to obtain an application form or for further information.